Search / Trial NCT06230575

Locoregional Blocks for Breast Cancer Surgeries

Launched by NATIONAL CANCER INSTITUTE, EGYPT · Jan 21, 2024

Trial Information

Current as of October 08, 2024

Recruiting

Keywords

Description

Numerous pain relief techniques, including several new regional anesthesia techniques, are available for control of acute pain after breast surgery.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • * female cancer breast patient
  • * age from 18- 65
  • Exclusion Criteria:
  • * coagulation defect
  • * Patient refusal
  • * abnormal kidney and or liver function tests

About National Cancer Institute, Egypt

The National Cancer Institute, Egypt, is a premier research institution dedicated to advancing cancer prevention, treatment, and care through innovative clinical trials and comprehensive research initiatives. As a leading sponsor of clinical studies, the Institute focuses on understanding cancer biology, improving therapeutic strategies, and enhancing patient outcomes. With a commitment to scientific excellence and collaboration, the National Cancer Institute plays a crucial role in addressing the cancer burden in Egypt and the broader region, fostering partnerships with local and international researchers to drive forward the frontiers of oncology.

Locations

Cairo, , Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0